ZVRA

Zevra Therapeutics, Inc. Common Stock

11.32

USD

-0.26

-2.25%

Sep 23, 15:59 UTC -4

Closed

After-Market

11.32

0.00

+0.04%

ZVRA Earnings Reports

Positive Surprise Ratio

ZVRA beat 22 of 43 last estimates.

51%

Next Report

Date of Next Report

Nov 03, 2026

Estimate for Q3 26 (Revenue/ EPS)

$37.82M

$0.15

Implied change from Q2 26 (Revenue/ EPS)

-4.64%

+7.14%

Implied change from Q3 25 (Revenue/ EPS)

+45.12%

-1600.00%

Zevra Therapeutics, Inc. Common Stock earnings per share and revenue

On Aug 05, 2026, ZVRA reported earnings of 0.14 USD per share (EPS) for Q2 26, beating the estimate of 0.10 USD, resulting in a 27.85% surprise. Revenue reached 39.66 million, compared to an expected 34.56 million, with a 14.77% difference. The market reacted with a +12.82% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 7 analysts forecast an EPS of 0.15 USD, with revenue projected to reach 37.82 million USD, implying an increase of 7.14% EPS, and decrease of -4.64% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Champions Oncology, Inc.

Report Date

Sep 10, 2026 For Q1 27

Estimate

-$0.01

Actual

-$0.03

Surprise

-194.12%

PharmaCyte Biotech, Inc. Common Stock

Report Date

Sep 14, 2026 For Q1 27

Estimate

Actual

-$0.54

Surprise

FAQ

What were Zevra Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Zevra Therapeutics, Inc. Common Stock reported EPS of $0.14, beating estimates by 27.85%, and revenue of $39.66M, 14.77% above expectations.

How did the market react to Zevra Therapeutics, Inc. Common Stock's Q2 2026 earnings?

The stock price moved up 12.82%, changed from $10.53 before the earnings release to $11.88 the day after.

When is Zevra Therapeutics, Inc. Common Stock expected to report next?

The next earning report is scheduled for Nov 03, 2026.

What are the forecasts for Zevra Therapeutics, Inc. Common Stock's next earnings report?

Based on 7 analysts, Zevra Therapeutics, Inc. Common Stock is expected to report EPS of $0.15 and revenue of $37.82M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.